Johannes Fredrik Grimmer, MD | |
100 N Medical Dr, Suite 4500, Salt Lake City, UT 84113-1103 | |
(801) 662-5671 | |
Not Available |
Full Name | Johannes Fredrik Grimmer |
---|---|
Gender | Male |
Speciality | Otolaryngology - Pediatric Otolaryngology |
Location | 100 N Medical Dr, Salt Lake City, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477643070 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YP0228X | Otolaryngology - Pediatric Otolaryngology | 5856707-1205 (Utah) | Primary |
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.
A national study by researchers at the National Center for Children in Poverty (NCCP), Columbia University Mailman School of Public Health-- shows an uneven picture of states' use of Medicaid to help families with young children gain access to mental health services
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
› Verified 9 days ago
Entity Name | University Of Utah Adult Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.
A national study by researchers at the National Center for Children in Poverty (NCCP), Columbia University Mailman School of Public Health-- shows an uneven picture of states' use of Medicaid to help families with young children gain access to mental health services
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
› Verified 9 days ago
Entity Name | University Of Utah Pediatric Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.
A national study by researchers at the National Center for Children in Poverty (NCCP), Columbia University Mailman School of Public Health-- shows an uneven picture of states' use of Medicaid to help families with young children gain access to mental health services
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Johannes Fredrik Grimmer, MD Po Box 581094, Salt Lake City, UT 84158-1094 Ph: (801) 213-3800 | Johannes Fredrik Grimmer, MD 100 N Medical Dr, Suite 4500, Salt Lake City, UT 84113-1103 Ph: (801) 662-5671 |
News Archive
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Vivakor, Inc. today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device.
A national study by researchers at the National Center for Children in Poverty (NCCP), Columbia University Mailman School of Public Health-- shows an uneven picture of states' use of Medicaid to help families with young children gain access to mental health services
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
› Verified 9 days ago
Dr. Kendall M. Burgett, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-662-5663 | |
Dr. Jason P Hunt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Russell Jon Ord, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 333 S 900 E, Salt Lake City, UT 84102 Phone: 801-535-8185 Fax: 801-355-4011 | |
Dr. David Parker Hill, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2000 S 900 E, Salt Lake City, UT 84105 Phone: 801-464-7660 Fax: 801-464-7558 | |
Dr. Bethany R Powers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6322 S 3000 E Ste 170, Salt Lake City, UT 84121 Phone: 801-513-3223 | |
Christopher A. Hamilton, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 North Medical Dr Som 3c120, Salt Lake City, UT 84132 Phone: 801-581-7514 | |
Quinn Taylor Orb, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Som 3c-120, Salt Lake City, UT 84132 Phone: 801-581-7514 Fax: 801-585-5744 |